Related Experiment Video
Updated: Jul 21, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
[Parkinson syndrome and cognitive disorders]
1Semmelweis Egyetem, Altalános Orvosi Kar, Neurológiai Klinika, 1083 Budapest, Balassa u. 6. szirmai@neur.sote.hu
Cognitive decline in Parkinson's disease (PD) involves speech, memory, and planning deficits, worsening with disease progression. This impairment is linked to neurotransmitter system damage and is not improved by L-dopa treatment.
Area of Science:
- Neuroscience
- Neurology
- Pathology
Context:
- Parkinson's disease (PD) is characterized by progressive cognitive deterioration affecting executive functions.
- Cognitive deficits in PD correlate with motor symptoms and involve multiple neurotransmitter systems beyond dopamine.
- Neurodegenerative changes, including Lewy bodies and vascular pathology, contribute to cognitive impairment in PD.
Purpose:
- To explore the multifaceted nature of cognitive impairment in Parkinson's disease.
- To examine the relationship between cognitive disability and Parkinsonian syndromes in various neurodegenerative disorders.
- To differentiate cognitive profiles in PD from related conditions like Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Multiple System Atrophy (MSA), Frontotemporal Dementias (FTD), Alzheimer's disease, Cortical Lewy Body Disease (CLBD), and Vascular Parkinsonism (VP).
Summary:
- Cognitive decline in PD encompasses deficits in fluency, word finding, working memory, planning, and flexibility.
- Neurotransmitter depletions (dopaminergic, noradrenergic, serotoninergic, cholinergic) and functional circuit disabilities contribute to cognitive symptoms.
- Parkinsonism can occur in other dementias (FTD, AD, CLBD), and dementia can be an early sign in CLBD, with varying correlations to motor severity.
- Vascular Parkinsonism presents with dementia and gait issues, unresponsive to L-dopa, and shows distinct neuropathology without substantia nigra cell loss.
Impact:
- Understanding the complex etiology of cognitive impairment in PD and related disorders is crucial for accurate diagnosis and management.
- Differentiating PD-related cognitive changes from other parkinsonian syndromes aids in targeted therapeutic strategies.
- Highlights the need for comprehensive assessment of cognitive function in patients with parkinsonian syndromes.
More Related Videos
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease l: Introduction
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll